Article
Intestinal Transgene Delivery with Native <i>E. coli</i> Chassis Allows Persistent Physiological Changes
2021-11-12
Abstract excerpt
<h4>ABSTRACT</h4> Live bacterial therapeutics (LBT) could reverse disease by engrafting in the gut and providing persistent beneficial functions in the host. However, attempts to functionally manipulate the gut microbiome of conventionally-raised (CR) hosts have been unsuccessful, because engineered microbial organisms (i.e., chassis) cannot colonize the hostile luminal environment. In this proof-of-concept study...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1990c1c6-3817-5d4a-8d64-8d447b7c5ae7
- DOI
- 10.1101/2021.11.11.468006
